Medline sets terms for massive $5.37B Nasdaq IPO
Medline has put forward terms for an absolutely massive IPO, which could see the medical device manufacturing and distribution giant raise as much as $5.37 billion if all goes to…
FDA clears Resmed AI for personalizing CPAP settings
Resmed believes its artificial intelligence-powered approach to personalizing the settings of its connected CPAP machines can lead to better sleep for people with obstructive apnea. Now the FDA has given…
Stryker promotes new president, COO to help lead its M&A strategy
Stryker, with its eye on tuck-in acquisitions and streamlining its business core, has promoted 27-year veteran Spencer Stiles to president and chief operating officer to help oversee its global business…
FDA panel votes against J&J’s novel shunt implant for heart failure
Johnson & Johnson’s billion-dollar bet on a novel implant for heart failure hit a roadblock this week, with an FDA advisory panel unanimously voting against its risk-benefit profile. The V-Wave…
Natera buys Foresight Diagnostics in cancer testing deal worth up to $450M
Natera is looking to grow its portfolio of tools to detect the recurrence of cancer with a deal to acquire Foresight Diagnostics, the Stanford University spinout and developer of blood…
Cancer blood test developer Freenome to go public in $330M SPAC deal
Freenome is taking itself public via a special purpose acquisition company, also known as a SPAC deal, to help raise funds in preparation for the planned 2026 launch of its…
GE HealthCare, Mayo Clinic launch digital twin project for personalizing radiation cancer therapy
GE HealthCare and the Mayo Clinic are expanding their long-running collaborative work to now include the development of new personalized radiation therapy approaches for cancer, with a plan to bring…
After more than 20 years, Medtronic claims deep brain stimulation approval for dystonia
In 2003, Medtronic first received a humanitarian green light from the FDA to offer its deep brain stimulation implants to treat the symptoms of dystonia—the painful movement disorder that can…
Medtronic’s Hugo surgical robot secures US clearance
Hugo is heading to the U.S., with Medtronic finally securing a stateside clearance for its robotic surgery platform. The FDA granted an initial green light to the soft-tissue system for…
FDA approves next-gen prostate cancer PSA test from Cleveland Diagnostics
The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test,…